Hepatocyte growth factor (HGF) is a fibroblast-derived protein that affects the growth, motility, and differentiation of epithelial cells including epidermal keratinocytes. To investigate the role of HGF in cutaneous biology and to explore the possibility of using it in a tissue engineering approach, we used retroviralmediated gene transfer to introduce the gene encoding human HGF into diploid human keratinocytes. Modified cells synthesized and secreted significant levels of HGF in vitro and the proliferation of keratinocytes expressing HGF was enhanced compared with control unmodified cells. To investigate the effects of HGF in vivo, we grafted modified keratinocytes expressing HGF onto athymic mice using acellular dermis as a substrate. When compared with controls, HGF-expressing keratinocytes formed a hyperproliferative epidermis. The epidermis was thicker, had more cells per length of basement membrane, and had increased numbers of Ki-67-positive proliferating cells, many of which were suprabasal in location. Hyperproliferation subsided and the epidermis was equivalent to controls by 2 weeks, a time frame that coincides with healing of the graft. Transient hyperproliferation may be linked to the loss of factors present in the wound that activate HGF. These data suggest that genetically modified skin substitutes secreting HGF may have applications in wound closure and the promotion of wound healing.
INTRODUCTION
thought to be a potent morphogenic factor (6) . And HGF promotes angiogenesis as demonstrated by the fact that Hepatocyte growth factor (HGF), a mitogen for hepa-HGF induces repair of wounds in endothelial monotocytes found in the serum of partially hepatectomized layers in vitro and it promotes neovascularization in the rats (23,28) and subsequently isolated from platelets rabbit cornea (7) . In the skin, HGF is produced by der- (29) and serum (36), has been shown to be identical to mal fibroblasts and is thought to be a paracrine factor, scatter factor (14, 35) , which causes epithelial cells to but its role in cutaneous physiology and repair is undissociate and become motile (33) . HGF is secreted as clear. a single-chain, biologically inert glycoprotein precursor
We and others (9) (10) (11) 34) have been investigating the (pro-HGF). Under appropriate conditions, such as tissue possibility of improving the ability of cultured skin damage, pro-HGF is converted into its bioactive form equivalents to repair wounds by genetically modifying by proteolytic digestion within two positively charged the cells to synthesize and secrete wound-healing growth amino acids (25). Mature HGF is a disulfide-linked hetfactors. Unlike gene therapy for inherited diseases where erodimer consisting of a 62-kDa α-chain and a 32/34the gene needed to be delivered is known, gene therapy kDa β-chain (30) . The receptor for HGF is expressed applications in tissue repair require investigation into the by normal epithelium of almost every tissue and it is a many growth factors involved in the wound repair prodisulfide-linked heterodimic membrane-bound tyrosine cess and identifying which growth factor has the desired kinase (4) .
effects. This requires in vitro as well as in vivo testing In addition to its effects on epithelial cell proliferain models that recapitulate the human process as closely tion and migration, HGF has several other interesting as possible. In this study, we investigated the effects of activities in tissue repair. HGF induces the formation HGF overexpression in a transgenic human epidermis. of branching tubules and gland-like structures and is Retroviral-mediated gene transfer was used to introduce 386 HAMOEN AND MORGAN the HGF gene into human keratinocytes and the effects after cocultivation, modified cells were dissociated and parallel cultures were prepared for proliferation and mi-of growth factor expression were examined in vitro as well as in vivo, by analyzing skin equivalents of keratin-gration studies and grafting. Unmodified control cells were cultured on a feeder layer of 3T3-J2 cells. ocytes seeded on acellular dermis. Proliferation of keratinocytes expressing HGF was enhanced and these cells Measurement of HGF Production formed a hyperproliferative epidermis in vitro and after by Modified Keratinocytes transplantation to athymic mice. Interestingly, hyperpro-Modified keratinocytes (10 6 ) were plated in a 75-cm 2 liferation was transient and subsided after 2 weeks, sugflask (containing 2 × 10 6 3T3-J2 feeder layer cells) and gesting that HGF's actions were limited by a process grown to confluence. Fresh medium was added (15 ml), that coincided with the healing of the graft. These findand portions (0.5 ml) of the culture medium were reings provide additional support for the role of HGF as a moved over a 7-day period. The level of HGF producmediator of human epidermal proliferation and the raise tion was measured by an ELISA. Cells were trypsinized the possibility of using genetically modified skin substiand counted, and protein production was normalized to tutes secreting HGF for applications in tissue repair.
cell number. Medium conditioned by unmodified kera-
MATERIALS AND METHODS
tinocytes was used as a control.
Construction of Recombinant Retrovirus
Proliferation Assay A cDNA encoding human HGF was kindly provided Cells were plated at 4 × 10 3 /well in a 96-well plate. by Dr. Reze Zarnegar of the University of Pittsburgh Cells were grown in keratinocyte basal medium (KBM, and was inserted into the NcoI and BamHI site of the Clonetics, San Diego, CA) supplemented with hydrocor-MFG retroviral vector by a two-step procedure. The vectisone (0.5 µg/ml), bovine pituitary extract (BPE, 30 µg/ tor, pSPORT-HGF, was digested with NcoI and BamHI ml), epidermal growth factor (EGF, 0.1 ng/ml), insulin and a 1381-bp fragment encoding the 3′ end of HGF (0.5 µg/ml), and gentamicin/amphotericin-B (50 µg/ml was gel purified and ligated into the MFG vector, which and 50 ng/ml) (Clonetics). At various times, cells were had been digested with NcoI and BamHI and gel puriwashed with phosphate-buffered saline (PBS) containing fied. To facilitate the moving of the 5′ end of HGF, we 1 mM MgCl 2 and fixed in trichloroacetic acid (10%). digested pSPORT-HGF with BstEII and SphI and puri-After 12 days, all wells were stained with orange-G fied the large vector fragment. Into this vector, we (1.5% orange G, 0.5% acetic acid; 5 min, room temperacloned two complementary synthetic oligonucleotides ture) and washed with 1% acetic acid. The bound dye (5′-cacatgtgg-3′ and 5′-gtcacccacatgtgcatg-3′), which, was solubilized with buffer (10 mM Tris, pH 7.4) and when annealed, have ends compatible with BstEII and the optical density at 490 nm was determined for tripli-SphI and also create a new AflIII site at the translational cate samples. start codon. To complete MFG-HGF, we cut the modi-To measure cell growth and the requirements for fied pSPORT with AflIII and NcoI, isolated an 804-bp added growth factors in 12-well dishes, modified and fragment encoding the 5′ end of HGF, and ligated this unmodified keratinocytes were subcultured (4 × 10 6 into the NcoI site of the MFG vector containing the 3′ cells/10 cm dish) in keratinocyte basal medium (KBM, end of HGF. The sequences of the oligonucleotides in Clonetics) with additives as above. After 2 days, cells the final construct were verified by DNA sequencing.
were trypsinized, washed in serum-free medium, and Keratinocyte Cell Culture and Gene Transfer seeded at 10 5 cells/well per 12-well plate (Falcon). Cells on 12-well plates were grown in KBM, supplemented Normal human keratinocytes derived from neonatal with all additives (HC, BPE, insulin, EGF) or in the abforeskins (four different strains) were cultured using a sence of one or two additives (insulin, EGF). Cells were fibroblast feeder layer as previously described (9) . Swiss formalin fixed at days 3, 6, 9, and 12 and stained with mouse 3T3-J2 feeder cells (kindly provided by H.
Rhodamine B (1%). Green, Harvard Medical School) and virus-producing cells were routinely passaged in Dulbecco's modified Composite Skin Grafts and Transplantation Eagle's medium (high glucose) (Gibco BRL, Gaithersburg, MD), supplemented with 10% bovine calf serum Cadaver skin was obtained from the Shriners Hospital skin bank and processed as previously described (22) (HyClone, Logan, UT) and penicillin/streptomycin (100 IU/ml and 100 mg/ml, Boehringer Mannheim, Indianap-to obtain acellular dermis. Acellular dermis was cut into 1 × 1-cm pieces, and each piece was placed in a 35-mm olis, IN). Keratinocytes were genetically modified as previously described (26). Briefly, preconfluent primary tissue culture dish, papillary side up. Unmodified and modified keratinocytes were seeded onto the surface of cultures were dissociated and cells were passed onto mitomycin C-treated virus-producing cells. Four to 6 days each piece of dermis (2.5 × 10 5 cells) in keratinocyte seeding medium (described below) using methods simi-losum were measured in the HGF-overexpressing grafts versus the unmodified grafts using Image Tool Process-lar to those previously described (22) with several different media (31) . After approximately 2 h, the cell-seeded ing Software. The numbers are an average of six random samples of each time point using three different grafts dermis was submerged in keratinocyte seeding medium for 24 h. Keratinocyte seeding medium was a 3:1 mix-and were measured from the following length of grafts: 3.7 mm (day 3), 3.7 mm (day 5), 3.6 mm (day 7), and ture of Dulbecco's modified Eagle's medium (high glucose) (Gibco BRL) and Ham's F-12 medium (Gibco 3.4 mm (day 14) for control grafts in vitro; 3.8 mm (day 3), 3.6 mm (day 5), 3.7 mm (day 7), and 3.6 mm (day BRL) supplemented with 1% FBS (JRH Bioscience), 10 −10 M cholera toxin (Vibrio Cholerae, Type Inaba 569 14) for HGF-expressing grafts in vitro; 4.5 mm (1 week), 4.9 mm (2 weeks), and 4.7 mm (4 weeks) for B; Calbiochem, La Jolla, CA), 0.2 µg/ml hydrocortisone (Calbiochem), 5 µg/ml insulin (Novo Nordisk, control graft in vivo; 4.6 mm (1 week), 4.1 mm (2 weeks), and 4.1 mm (4 weeks) for HGF-expressing Princeton, NJ), 50 µg/ml ascorbic acid (Sigma Chemical), and 100 IU/ml and 100 µg/ml penicillin/streptomy-grafts in vivo. The edges of the grafts were excluded. Statistical comparisons were performed using two-way cin (Boehringer Mannheim Co.). After 24 h, keratinocyte seeding medium was removed and the grafts were ANOVA and the Tukey test for multiple comparison. Cryostat sections (6 µm), treated with blocking solu-submerged for an additional 48 h in keratinocyte priming medium. Keratinocyte priming medium was com-tion (10% normal horse serum in PBS) for 1 h at room temperature, were incubated with a rabbit anti-human posed of keratinocyte seeding medium supplemented with 24 µM bovine serum albumin (Sigma Chemical), monoclonal Ki-67 antibody, a nuclear cell proliferationassociated antigen (Hofmann-Wellenhof et al., 1990) 1.0 µM L-serine (Sigma Chemical), 10 µM L-carnitine (Sigma Chemical), and a cocktail of fatty acids: 25 µM (1:100) (PharMingen, San Diego, CA), for 30 min at room temperature. Slides were washed 5 × 5 min with oleic acid (Sigma Chemical), 15 µM linoleic acid (Sigma Chemical), 7 µM arachidonic acid (Sigma Chemical), PBS, then incubated with a biotinylated secondary antibody (Vector, Burlingame, CA) for 30 min. The slides and 25 µM palmitic acid (Sigma Chemical) (5) . After 48 h in priming medium, the grafts were raised to the were washed 5 × 5 min in PBS and then incubated with avidin/HRP (Vector) for 30 min. Slides were washed air/liquid interface by placing them on stainless steel screens and cultured for 3-14 days with air/liquid inter-5 × 5 min in PBS, stained with DAB (peroxidase substrate kit, Vector), coverslipped using crystal mounting face medium composed of serum-free keratinocyte priming medium supplemented with 1.0 ng/ml epider-solution, and dried overnight. The primary antibody was diluted in blocking solution, the secondary antibody was mal growth factor (Collaborative Biomedical Products, Bedford, MA). diluted in PBS, and the avidin/HRP was diluted in distilled water. The number of Ki-67-positive cells was Grafting was performed in a laminar flow hood using 6-to 8-week-old NIH Swiss nu/nu mice (Taconic Farms, measured per length of basement membrane using Image Tool Processing Software. The numbers are an aver-Germantown, NY) anesthetized with an IP injection of 2,2,2-tribromoethanol (0.58 mg/g body weight; Aldrich, age of six random samples of each time point using three different grafts. Ki-67-positive cells, located in the Milwaukee, WI). The grafts were used after 7 days at the air/liquid interface and grafted as previously de-basal or the immediately suprabasal layer, were counted from the following length of grafts: 4.0 mm (day 3), 3.9 scribed (21) . Briefly, scissors were used to create a fullthickness 1 × 1-cm defect down to the fascia of the dor-mm (day 5), 4.2 mm (day 7), and 3.9 mm (day 14) for control grafts; 4.0 mm (day 3), 4.9 mm (day 5), 3.9 mm sal musculature. The composite graft was placed onto the wound, trimmed to fit precisely in the defect, and (day 7), and 3.3 mm (day 14) for HGF-expressing grafts (these were presented as a percentage of the total num-stitched in four corners. The wound was covered up with bandages that were removed after 2 weeks. ber of basal cells). The edges of the grafts were excluded. Statistical comparisons were performed using Histology and Immunostaining of Skin Equivalents two-way ANOVA and the Tukey test for multiple comparison. Skin equivalents in vitro were harvested after 3, 5, 7, and 14 days at the air/liquid interface studies and the in RESULTS vivo grafts were harvested after 7, 14, and 28 days. The
Genetically Modified Human Keratinocytes tissue was either fixed in 10% formalin or fixed in 4% Secrete HGF paraformaldehyde, frozen, and stored at −80°C until cryosectioned. Paraffin-embedded sections (6 µm) were
The structure of the retroviral vector used to express the HGF gene in human keratinocytes is shown in Fig-stained with hematoxylin/eosin. The number of cells per unit basement membrane and the thickness of the epi-ure 1A. Secondary cultures of human keratinocytes established from neonatal foreskins were cocultivated with dermis from the stratum basale up to the stratum granu- mitomycin C-treated Ψ-CRIP cells producing the HGF at early time points, versus control cells. Both reached similar cell densities at confluence. recombinant retrovirus. After 4 days of cocultivation, the virus-producing cells were removed and the keratin-Optimal keratinocyte growth in serum-free medium requires added EGF, hydrocortisone, BPE, and insulin. ocytes were dissociated using trypsin and passed onto a normal 3T3 fibroblast feeder layer. To measure the To determine if HGF expression altered the requirements for these factors, control and modified cells (10 5 production of HGF, modified keratinocytes were grown to confluence, fresh was medium added, and portions of cells/well) were grown in serum-free medium with or without one or two of the key growth factors. Cells were the culture medium were removed over a 6-day period. The level of HGF production was measured by ELISA.
formalin fixed and stained after 3, 6, 9, and 12 days of growth. In all conditions tested, there was a slight HGF was continuously secreted by modified cells up to 6 days with an average daily secretion rate of 26 ng/10 7 enhancement to the growth of HGF-expressing cells compared with control cells. However, like control cells, cells/24 h (Fig. 1B) . Medium conditioned by unmodified keratinocytes did not contain any HGF (data not shown).
growth of HGF-expressing cells was sensitive to the removal of growth factors, particularly insulin (Fig. 2B ).
Expression of HGF Modifies Keratinocyte Proliferation
Thus, expression of HGF did not dramatically alter the To determine if the growth of HGF-expressing keragrowth factor requirements of modified keratinocytes. tinocytes was altered, we compared their growth to con-HGF-Expressing Keratinocytes Form trol cells in serum-free medium. At various times after a Hyperproliferative Epidermis In Vitro plating, the cells were fixed and cell density was determined using the orange-G assay ( Fig. 2A) . Proliferation
To determine if HGF expression had an effect on the formation of an epidermis, we cultured control or HGF-of the HGF-expressing cells was enhanced, particularly expressing keratinocytes on acellular dermis at the air/ the average thickness of the epidermis, we also measured the total surface area of the epidermis per length liquid interface. At 3, 5, 7, and 14 days the in vitro skin equivalents were fixed and stained. Keratinocytes in the of basement membrane. The epidermis formed by HGFexpressing keratinocytes was significantly thicker than basal layer were elongated and more densely packed in the HGF epidermis compared with the epidermis of un-the epidermis formed by control cells at all time points (p < 0.01) (Fig. 4C ). modified keratinocytes (Fig. 3A-D) . To verify this observation, we counted the number of cells per unit length
To determine if proliferation was altered, we stained tissue sections for Ki-67, a nuclear antigen associated of basement membrane. The HGF-expressing skin equivalents had significantly increased numbers of kera-with cell proliferation. The Ki-67 antigen is present in the nuclei of cells in late G 1 , S, G 2 , and M phases, but tinocytes per unit length of basement membrane compared with control epidermis at all four time points (p < is absent from the G 0 and the early G 1 phases. The HGF skin equivalents had significantly increased numbers of 0.01) (Fig. 4A) . To determine if there were changes to Ki-67-positive cells compared with the control skin grafts were fixed and stained. Both unmodified cells and cells expressing HGF developed a stratified epidermis equivalents in the basal layer at all time points (p < 0.05) (Fig. 5) . Moreover, the Ki-67-positive cells of con-consisting of stratum basale, spinosum, granulosum, and corneum, indicating complete terminal differentiation trol skin equivalents were predominantly in the basal layer, with few positive cells in the suprabasal layer. In (Fig. 3E-H) . One week after transplantation, the epidermis of the HGF-expressing cells was hyperproliferative addition to increased numbers of Ki-67-positive cells in the basal layer, HGF skin equivalents had significantly compared with the epidermis formed by control unmodified cells. And, as seen with the in vitro skin equiva-increased numbers of Ki-67-positive cells in the suprabasal layer at day 3 and 5 (p < 0.05).
lents, basal cell density was increased and the cells had an elongated morphology. At 2 and 4 weeks, hyperpro-Hyperproliferation of the HGF Epidermis Is Transient liferation of the HGF-expressing grafts subsided and the In Vivo morphologic appearance of the epidermis was indistin-To determine if HGF expression had an effect in guishable from the control epidermis. To document vivo, we transplanted the composite grafts to athymic these changes, we calculated the number of cells per unit mice. At 1, 2, and 4 weeks after transplantation, the length of basement membrane and determined the thick- ness of the epidermis. At 1 week, the epidermis was HGF-expressing cells was enhanced compared with control unmodified cells. Skin equivalents generated from significantly thicker (p < 0.01) and had a significantly increased number of keratinocytes per unit length of unmodified and HGF-expressing keratinocytes both formed a stratified epidermis, complete with stratum basement membrane compared with the control epidermis (p < 0.01). At 2 and 4 weeks, the density of basal granulosum and stratum corneum in vitro and in vivo. When compared with controls, HGF-expressing skin cells was not significantly different from control grafts, but the thickness of the epidermis was still increased equivalents formed a thicker epidermis in vitro with increased basal cell density and increased numbers of ( Fig. 4B, D) .
Ki-67-positive cells in the basal as well as suprabasal DISCUSSION layers. After transplantation, HGF-expressing grafts In this study, we investigated the in vitro and in vivo formed a thicker epidermis in the first week after transeffects of expressing HGF by a human skin equivalent.
plantation, but hyperproliferation subsided by 2 weeks Diploid human keratinocytes genetically modified and the epidermal thickness and basal cell density were by retroviral-mediated gene transfer synthesized HGF comparable with control grafts. at levels up to 26 ng/10 7 /24 h and proliferation of Our results are consistent with earlier work showing that HGF recombinant protein enhances cell growth and tocyte growth factor activator (HGFA) (homologous to coagulation factor XII) (24) , coagulation factor XII itself DNA synthesis of keratinocytes in culture (20) . Growth of the HGF-expressing keratinocytes was also enhanced (32) , and urokinase-type (uPA) and tissue-type (tPA) plasminogen activators (19) . In another study by our over control cells in our study, but the modified cells were still dependent on added insulin and EGF for opti-group, keratinocytes genetically modified to express keratinocyte growth factor (KGF) formed a thicker and hy-mal growth. In a previous study, we showed that introduction of a new autocrine loop by genetic modification perproliferative epidermis in vivo and this hyperproliferation persisted for at least 6 weeks after transplantation. could alter growth factor requirements of human keratinocytes. In that study, keratinocytes modified to express In contrast to HGF, KGF is known to be secreted as an active molecule and does not require activation (1); thus, IGF-1 no longer required added insulin for growth in vitro (10) . The new HGF autocrine loop engineered in transient hyperproliferation of HGF grafts could be due to the disappearance or downregulation of an activator the present study appears to activate keratinocyte proliferation to a level beyond the combination of insulin and of HGF. The four activators of HGF have different potencies EGF, but it does not obviate the need for these growth factors. and are produced by two different sources. HGFA and factor XIIa are both present in serum, whereas uPA and This observation is also consistent with the hyperproliferative nature of the skin equivalents generated from tPA are produced by keratinocytes in vitro (18) as well as in vivo (17). In vitro, HGFA has been shown to be these cells. When seeded on acellular dermis and exposed to the air/liquid interface, cultured keratinocytes the most potent activator of HGF with an activity that is 50-fold higher than factor XIIa and about a 1000-fold complete the differentiation pathway by forming welldeveloped granular, cornified, and basal cell layers in higher than uPA and tPA.
In our system, it is unclear which of these factors is vitro. In this stratified and differentiated three-dimensional system, cultured keratinocytes are no longer ad-activating HGF and it is possible that activation could explain the differences in hyperproliferation between in herent to tissue culture plastic at relatively low density. Rather, basal cells, resting on a basement membrane, vitro and in vivo. The initial seeding medium used to generate the skin equivalents in vitro contains serum and proliferate and give rise to cells that migrate upward to differentiate and form successive layers of the epider-may be a source of HGFA. Although subsequent media changes are serum free, serum elements may persist in mis. Cell proliferation of skin equivalents generated from control unmodified keratinocytes in medium con-the skin equivalent. Alternatively, uPA or tPA produced by keratinocytes may be activating HGF. In vivo during taining added EGF and insulin is confined largely to the basal layer as it is in the normal epidermis. In contrast, the first week after transplantation all the activators of HGF may be available during the healing of the graft. skin equivalents generated from keratinocytes expressing HGF are hyperproliferative. In addition to being After the initial injury subsides, sources of HGFA and factor XIIa might be limited; thus, HGF activation thicker and having increased numbers of proliferating cells on the basal layer, the HGF epidermis also has pro-would be dependent on keratinocyte-produced uPA and/ or tPA. In normal epidermis uPA is more abundant than liferating cells in the suprabasal layer. This indicates that, in addition to stimulating proliferation, HGF is also tPA (17,27); however, in the epidermis from lesions of patients with a variety of cutaneous diseases, tPA is pre-able to mediate a change to the cellular organization of the epidermis by expanding the proliferative compart-dominant (3). In future studies, it will be important to determine which of the factors is activating HGF and ment to the suprabasal layer. We observed similar changes to human skin equivalents when they were how this activation is linked to the hyperproliferative state. genetically modified to express keratinocyte growth factor (2) .
Skin substitutes containing HGF-expressing keratinocytes may be useful in cutaneous tissue repair and Hyperproliferation of the HGF-expressing grafts in vivo was transient and subsided by 2 weeks. Several wound healing. Allografts of cultured skin cells have been approved for the healing of ulcers (12). This heal-factors could account for the transient hyperproliferation. Previous studies have shown that retroviral vector ing process is complex but probably involves in part the local secretion of growth factors from the skin substi-expression may subside in vivo (8, 13) ; thus, diminution of HGF expression could explain why hyperproliferation tute. Genetic modification can be used to enhance the pharmacological activity of these allogeneic skin substi-is transient. Another possibility might be the lack of activation of HGF. HGF is synthesized and secreted as a tutes by engineering them to synthesize and secrete high levels of growth factors, which aid in wound closure. single-chain molecule and must be proteolytically converted to the active heterodimeric form (25). Four prote-In addition to direct effects on keratinocyte growth and migration, physiologic quantities of recombinant HGF ases have been reported to activate HGF in vitro: hepa- 
